The immune response to infection depends centrally on the T lymphocytes of the immune system, and the detection of infection by T lymphocytes depends in turn on the presentation of antigen to the T cells by molecules encoded in the major histocompatibility complex (MHC). The biological function of these molecules is to bind proteolytic fragments (peptides) derived from foreign proteins generated inside cells either from intracellular parasites such as viruses, or from microorganisms or toxins internalized by cells, and display them on the cell surface where the complex of MHC molecule and peptide can be recognized by T cells.
There are three points in the life of a T cell at which the recognition of an MHC-peptide complex has a pivotal effect: the first is when the repertoire of T-cell antigen receptors is selected during the maturation of T lymphocytes in the thymus; the second is at the initiation of an immune response in the lymph node, where specialized antigen-presenting cells activate the proliferation of antigen-specific T cells and their differentiation into effector cells; and the third is at the final encounter of the effector T cell with its target.
The basic cell biology of antigen presentation is now broadly understood, and the focus of interest is shifting to modulations of the basic process that may answer broader biological questions about how the T-cell repertoire is selected in the thymus and modified by specialized antigen-presenting cells in the lymph nodes. It has also become clear that viruses have evolved a remarkable arsenal of devices for interfering with the formation of peptide-MHC complexes and their migration to the cell surface, and thereby avoiding detection by T cells.
The detection of infection
There are two types of MHC molecule and two pathways of antigen processing and presentation. Broadly speaking, MHC class I molecules bind and display peptides derived from intracellular parasites (notably viruses) proliferating in the cytoplasm, whereas MHC class II molecules bind and display peptides derived from extracellular microorganisms and their products which have been internalized and degraded in the vesicular compartments of cells. The peptide-loaded MHC molecules that appear on the cell surface are then differentially recognized by the two major classes of T cell: MHC class I molecules are recognized by cytotoxic T cells, which directly destroy cells infected with viruses, whereas MHC class II molecules are recognized by helper T cells, which generally act indirectly by activating B lymphocytes to produce antibodies and macrophages to destroy bacteria, and are thought to be necessary for effective cytotoxic T lymphocyte responses to cells harbouring viruses.
The main structural features of the two classes of MHC molecule are illustrated in Figure 1 . The two most distinctive characteristics of MHC molecules, shared by both classes, are their extraordinary polymorphism and the peptide-binding cleft formed by their membrane-distal domains, in which the polymorphic amino acids are concentrated. The polymorphism of the peptide-binding domains, and the co-expression of MHC molecules from more than one gene, enable the MHC molecules of any given individual to bind a wide range of peptides where they can be efficiently recognized by the highly variable antigen receptors of T lymphocytes.
The differential recognition of MHC class I molecules by the antigen receptors of cytotoxic T cells, and of MHC class II molecules by those of helper T cells, is promoted by the co-receptors CD8 and CD4 which are expressed on T cells and recognize nonpolymorphic determinants of MHC class I molecules and MHC class II molecules respectively. CD4 and CD8 were originally identified as markers for T cells of distinct functional classes and purists refer to CD4 and CD8 T cells, not helper and cytotoxic cells.
The distinct roles of the two classes of MHC molecule are reflected in their tissue distribution. MHC class I molecules are required to flag viral infection and because almost any cell can be infected with a virus, all nucleated cells express MHC class I molecules. MHC class II molecules, by contrast, are important chiefly in communication between cells of the immune system -for example, the display of internalized antigen to T cells by specialized antigen-presenting cells at the initiation of an immune response, or by the B cells and macrophages that are activated by Magazine R829
Figure 1
The structure of MHC molecules. The MHC class I and MHC class II molecules are structurally homologous, each having two immunoglobulin-like membrane-proximal domains and two membrane-distal domains that form a peptide-binding cleft. But whereas the α and β chains of the MHC class II molecule contain one membrane-proximal and one distal domain each and are both encoded in the MHC, the MHC class I α chain contains both membrane-distal domains and the β chain, β 2 -microglobulin (β 2 -m), is encoded outside the MHC on a separate chromosome. Three different genes encode polymorphic α chains of the MHC class I molecule and there are also several genes encoding each of the polymorphic α and β chains of the MHC class II molecules; β 2 -microglobulin is not polymorphic. Figure 2 ). For both classes of MHC molecule, the presence of bound peptide is necessary for the stable folding of the protein, and peptide loading -like protein folding -is a chaperoned process (see Figure 2) . The chaperoning of peptide loading has become known somewhat confusingly as peptide editing, the editorial function being the selection of peptides that bind stably to the MHC molecule. By releasing only stably folded complexes of MHC molecule and peptide, the chaperones are thought to ensure that MHC-peptide complexes with short half-lives rarely reach the cell surface; this is important because the induction of T-cell responses requires sustained display of the antigenic peptide on the presenting cell.
MHC class I MHC class II
How do MHC molecules avoid displaying self peptides? The answer is that they don't. The peptide-binding clefts of most MHC molecules are filled with self peptides but these complexes are ignored by T cells because those cells bearing receptors that recognize self peptides are eliminated during T-cell maturation in the thymus -a process called negative selection. Paradoxically, immature T cells are also positively selected in the thymus for recognition of self MHC plus foreign peptides, by a process that is still not understood. Differential peptide editing by thymic cells has attracted attention as a possible mechanism.
Selection of T cells in the thymus
During their maturation in the thymus, immature T cells (thymocytes) migrate through the thymic cortex to exit through the medulla. Positive selection is believed to occur at the surface of thymic epithelial cells in the cortex, and negative selection of potentially self-reactive cells at the surface of various cell types but particularly that of dendritic cells. Dendritic cells are concentrated at the junction of the thymic cortex and the medulla and are the most important and potent of the three types of specialized antigen-presenting cell responsible for the initiation of immune responses in response to infection (the other two are macrophages and B cells).
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Figure 2
Antigen processing and presentation pathways. Both MHC class I (yellow) and MHC class II (purple) molecules are synthesized with their extracellular domains projecting into the lumen of the endoplasmic reticulum (ER). The MHC class II molecule is prevented from binding peptides in the ER lumen by the invariant chain (blue) which binds to it and blocks the peptide-binding cleft. Instead of following the normal secretory pathway to the cell surface, MHC class II molecules are routed by the invariant chain into acidic endosomes containing internalized proteins from the cell exterior. In the endosomes, the invariant chain is degraded, leaving only a fragment, CLIP, still protecting the peptide-binding cleft. This is degraded and released when the MHC class II molecule binds to the chaperone DM (accompanied in some cells by DO, not shown here). The MHC class II molecule can then bind peptides derived from internalized proteins degraded in the endosome, is released from DM and proceeds to the cell surface. Newly synthesized MHC class I α chains bind successively to three chaperones (orange). The first is calnexin, which is replaced by calreticulin after β 2 -microglobulin is bound. Calreticulin and the MHC class I molecule then form a complex with tapasin, which binds the TAP transporter through which peptides generated by the degradation of proteins by proteasomes in the cytoplasm are transported into the lumen of the ER. Once peptide is bound, the MHC class I molecule is released to enter the secretory pathway to the cell surface. Clearly, the T-cell receptor specificities that are positively selected on the thymic epithelium must be distinct from those that are subsequently eliminated by dendritic cells otherwise no T cells would ever emerge from the thymus. Two main possibilities have been suggested to account for this difference. One is that the strength of the signal to the thymocytes varies between the thymic cortex and the medulla -because the density of antigen presented is different, or because of changes in the sensitivity of the developing thymocytes, or both. The other is that a different array of peptides is presented on cortical and medullary cells. This could in principle be achieved by differential peptide editing.
No definitive statement is at present possible on the mechanism of thymic selection, and a discussion of the evidence would require an article to itself. But two possibilities that have recently been considered as the basis for differential peptide editing are the enzymes that cleave the invariant chain, and the chaperones that regulate the loading of peptide in the acidic endosomes. Thus, for example, in thymic epithelial cells the invariant chain is cleaved by the endosomal protease cathepsin L, whereas in dendritic cells it is cleaved by a different member of the same enzyme family, cathepsin S. Although there is evidence that this does indeed result in the display of a different range of peptides on these two classes of cell, evidence for physiological effects on thymic selection is so far ambiguous.
A second recent focus of speculation is the nonpolymorphic MHC class II molecule DO. DO binds the chaperone DM, influencing its peptide editing function, and is expressed in B cells, thymic epithelium and possibly dendritic cells. All three of these cell types influence the T-cell repertoire: thymic epithelium and dendritic cells exercise positive and negative selection in the thymus, and B cells are thought to induce tolerance in the periphery to self peptides not encountered on thymic cells. On the basis of evidence that DO acts as an inhibitor of DM, it has been suggested that it may indiscriminately broaden the range of peptides allowed to reach the cell surface, thereby affecting selection of the T-cell repertoire in the thymus and the periphery (see Curr Biol 1998, 8:R128-R131). At this stage, however, the physiological action of DO is not clear, and it may operate as a co-chaperone with DM rather than as an inhibitor.
The best, therefore, that can be said about the contribution of recent research on antigen processing to the thymic selection problem is that it has suggested more avenues for exploration.
Sabotage strategies
The recognition of an increasing number of components of antigenpresentation pathways has recently been paralleled by the identification of an increasing repertoire of viral proteins that seem to have evolved for the express purpose of disabling them. The related chronic viruses cytomegalovirus, herpes simplex virus and Epstein-Barr virus, and more recently human immunodeficiency virus (HIV), seem to have converged on a number of devices for preventing, or at least delaying, their own detection.
The virus with the largest range of sabotage devices known so far is cytomegalovirus, a cause of respiratory disease particularly in immunocompromised individuals in whom it can be fatal. Cytomegalovirus blocks the up-regulation of MHC class II molecules by cytokines and disrupts peptide display by MHC class I molecules at four different points. One viral protein, pp65, interferes with proteolysis in the cytoplasm and inhibits the generation of antigenic peptides; a second, US6, binds to the TAP transporter and depresses peptide transport; a third, US3, binds to the MHC class I molecule and retains it in the ER by means of an ER retrieval signal in its tail; and two other proteins, US2 and US11, seem to reverse the protein translocation apparatus whereby membrane and secreted proteins are extruded into the lumen of the ER, so that MHC class I molecules are instead expelled into the cytoplasm whence they have no means of reaching the cell surface. The other chronic viruses also encode proteins that interfere with one or more of these processes.
Most recently, the Vpu and Nef proteins encoded by HIV have been implicated in the down-regulation of MHC class I expression in HIV-infected cells, Vpu by detaining the class I molecules in the ER and Nef by directing surface MHC class I molecules into coated pits through which they are internalized, routed into the lysosomal pathway and destroyed.
The hazard to the virus of downregulating MHC class I expression is that it thereby exposes itself to attack by natural killer cells which are programmed to destroy cells in the absence of surface MHC class I (see Curr Biol 1998, 8:R595-R597); but cytomegalovirus has outflanked even this default defence option, by evolving an MHC class I surrogate as a decoy.
It is a measure of the importance of antigen presentation to T cells that so many viral strategies have evolved in parallel to confound it.
